NEW YORK (GenomeWeb News) - Global Lifescience Solutions, a segment of non-profit safety testing firm NSF International, said this week that it will partner with the Michigan High Throughput Screening Center in Kalamazoo, Mich., to offer screening services that may help companies identify potential leads for drug discovery.
Â
Through the partnership, MHTSC will add high-content screening services from GLS to its current menu of high-throughput screening services.
Â
MHTSC, a non-profit located at Kalamazoo Valley Community College, will now provide prescreening services, assay development, development and optimization services, follow-up screening services, and will help companies examine multiple cellular targets and parameters in individually imaged cells. MHTSC does not charge licensing or royalty fees.
Â
"As more and more drug companies outsource their research and testing, our goal is to provide solutions that will expedite the drug development process," said Aline Lindbeck, general manager of the Ann Arbor-based GLS.
Â
GLS said it expects MHTSC to offer pre-screening services to biotechnology companies, government institutions, and to pharmaceutical companies that do not have in-house screening available.
Â
Financial terms of the agreement were not released.